Evaluation of Susceptibility to Antimycobacterial Drugs in Mycobacterium Tuberculosis Complex Strains Isolated from Cattle in Poland
- PMID: 29978051
- PMCID: PMC5894403
- DOI: 10.1515/jvetres-2017-0003
Evaluation of Susceptibility to Antimycobacterial Drugs in Mycobacterium Tuberculosis Complex Strains Isolated from Cattle in Poland
Abstract
Introduction: Tuberculosis is a highly infectious disease affecting humans and animals. It is caused by the Mycobacterium tuberculosis complex (MTBC) - Mycobacterium bovis and Mycobacterium caprae, which are aetiological factors of bovine tuberculosis (bTB). In Poland, the bTB eradication programme exists. Animals diagnosed with tuberculosis are in the majority of cases not treated, but removed from their herd and then sanitary slaughtered.
Material and methods: In total, 134 MTBC strains isolated from cattle in Poland were subjected to microbiological analysis. The resistance phenotype was tested for first-line antimycobacterial drugs used in tuberculosis treatment in humans: streptomycin, isoniazid, rifampicin, ethambutol, and pyrazinamide. The strains were isolated from tissues collected post mortem, so the test for drug resistance fulfilled only epidemiological criterion.
Results: The analysis of drug-resistance of MTBC strains revealed that strains classified as M. bovis were susceptible to 4 antimycobacterial drugs: isoniazid, rifampicin, streptomycin, and ethambutol, and resistant to pyrazynamide. The strains classified as M. caprae were sensitive to all tested drugs.
Conclusion: The results indicate that despite enormously dynamic changes in mycobacterial phenotype, Polish strains of MTBC isolated from cattle have not acquired environmental resistance. The strains classified as M. bovis are characterised by natural resistance to pyrazinamide, which is typical for this species.
Keywords: Mycobacterium tuberculosis complex; Poland; antimycobacterial drugs; bovine tuberculosis; cattle.
Conflict of interest statement
Conflict of Interests Statement: The authors declare that there is no conflict of interests regarding the publication of this article.
Figures
Similar articles
-
Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.BMC Vet Res. 2018 Sep 29;14(1):296. doi: 10.1186/s12917-018-1623-9. BMC Vet Res. 2018. PMID: 30268120 Free PMC article.
-
Evaluation of susceptibility to pyrazinamide and streptomycin, isoniazid, rifampin and ethambutol of Mycobacterium caprae strains isolated from European bison (Bison bonasus caucasicus) in the Bieszczady Mountains (Southern Poland).Pol J Vet Sci. 2024 Sep;27(3):475-479. doi: 10.24425/pjvs.2024.151739. Pol J Vet Sci. 2024. PMID: 39736130
-
[Investigation of Mycobacterium bovis subsp. bovis among the strains of Mycobacterium tuberculosis complex isolated in Düzce Province, Turkey].Mikrobiyol Bul. 2016 Jul;50(3):392-400. doi: 10.5578/mb.27784. Mikrobiyol Bul. 2016. PMID: 27525395 Turkish.
-
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].Kekkaku. 2001 Jan;76(1):33-43. Kekkaku. 2001. PMID: 11211781 Review. Japanese.
-
Overview and phylogeny of Mycobacterium tuberculosis complex organisms: implications for diagnostics and legislation of bovine tuberculosis.Res Vet Sci. 2014 Oct;97 Suppl:S5-S19. doi: 10.1016/j.rvsc.2014.02.009. Epub 2014 Feb 25. Res Vet Sci. 2014. PMID: 24630673 Review.
Cited by
-
Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.BMC Vet Res. 2018 Sep 29;14(1):296. doi: 10.1186/s12917-018-1623-9. BMC Vet Res. 2018. PMID: 30268120 Free PMC article.
References
-
- Aranaz A., Cousins D., Mateos A., Domínguez L.. Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov. Int J Syst Evol Microbiol. 2003;53:1785–1789. - PubMed
-
- Bailey S.S., Crawshaw T.R., Smith N.H., Palgrave C.J.. Mycobacterium bovis infection in domestic pigs in Great Britain. Vet J. 2013;198:391–397. - PubMed
-
- Bobadilla-del Valle M., Torres-Gonzälez P., Cervera-Hernändez M.E., Martínez-Gamboa A., Crabtree-Ramirez B., Chävez-Mazari B., Ortiz-Conchi N., Rodríguez-Cruz L., Cervantes-Sänchez A., Gudiño-Enríquez T., Cinta-Severo C., Sifuentes-Osornio J., Ponce de Leön A.. Trends of Mycobacterium bovis isolation and first-line anti-tuberculosis drug susceptibility profile: A fifteen-year laboratory-based surveillance. PLoS Negl Trop Dis. 2015 doi: 10.1371/journal.pntd.0004124. - DOI - PMC - PubMed
-
- Campbell T.A., Long D.B., Bazan L.R., Thomsen B.V., Robbe-Austerman S., Davey R.B., Soliz L.A., Swafford S.R., Ver Cauteren K.C.. Absence of Mycobacterium bovis in feral swine (Sus scrofa) from the southern Texas border region. J Wildl Dis. 2011;47:974–978. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources